Last update 24 Feb 2026

VBI-1501A

Overview

Basic Info

Drug Type
Prophylactic vaccine, Genetically engineered subunit vaccine
Synonyms
eVLP HCMV gB vaccine, VBI 1501A, VBI-1501
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious Diseases
Active Indication
Cytomegalovirus Infections
Inactive Indication-
Originator Organization
Epixis SAEpixis SA
Active Organization
Weill Cornell MedicineWeill Cornell MedicineVBI Vaccines, Inc.VBI Vaccines, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VBI-1501A
NCT02826798
/ CompletedPhase 1
A Phase 1 Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Candidate Human Cytomegalovirus Vaccine (VBI-1501) in Healthy Adults
100 Clinical Results associated with VBI-1501A
Login to view more data
100 Translational Medicine associated with VBI-1501A
Login to view more data
100 Patents (Medical) associated with VBI-1501A
Login to view more data
100 Deals associated with VBI-1501A
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cytomegalovirus InfectionsPhase 1
Canada
VBI Vaccines, Inc.VBI Vaccines, Inc.
23 Jun 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT02826798 (CTgov)
Phase 1
Cytomegalovirus Infections
128
(VBI-1501A: 0.5µg With Adjuvant)
ycxgvexprz = fociavqlwg gudputothz (xjznrrueiz, bltgtbhsnt - wuzhtdsakr)
View more
-
20 Apr 2020
(VBI-1501A: 1.0µg With Adjuvant)
ycxgvexprz = twrvgjlzfy gudputothz (xjznrrueiz, nnwoqkxzcj - uairejiryw)
View more
NCT02826798 (GlobeNewswire)
ManualManual
Phase 1
Cytomegalovirus Infections
125
doriashwcv(mtcvyhjtbm) = mboboupcpq pelbtarmab (udeiwbnacy )
View more
Positive
10 May 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free